Yujin  Hoshida

Dr. Yujin Hoshida

University of Texas Southwestern Medical Center, Dallas, USA
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
THTakaaki Higashi
Takaaki Higashi
SFScott L. Friedman
Scott L. Friedman
YHYujin Hoshida
Yujin Hoshida

1 March 2018 in Journal of Hepatology
Verified
Journal Article
Closed access
NFNaoto Fujiwara
Naoto Fujiwara
SFScott L. Friedman
Scott L. Friedman
NGNicolas Goossens
Nicolas Goossens
YHYujin Hoshida
Yujin Hoshida

6 February 2022 in Journal of Hepatology
Verified
Journal Article
Closed access
ASAmit Singal
Amit Singal
EZEmily Zhang
Emily Zhang
MNManasa Narasimman
Manasa Narasimman
NRNicole E. Rich
Nicole E. Rich
AWAkbar K. Waljee
Akbar K. Waljee
JMJorge A. Marrero
Jorge A. Marrero

1 December 2015 in Nature Immunology
Verified
Journal Article
Open access
PDF file
SFShlomi Finkin
Shlomi Finkin
DYDetian Yuan
Detian Yuan
ISIlan Stein
Ilan Stein
KTKoji Taniguchi
Koji Taniguchi
AWAchim Weber
Achim Weber
EPEli Pikarsky
Eli Pikarsky
Ectopic lymphoid structures develop at sites of chronic inflammation and are generally thought to be beneficial in the control of cancer. Pikarsky and colleagues show that these structures can instead nurture liver tumor progenitor cells. Ectopic lymphoid-like structures (ELSs) are often observed in cancer, yet their function is obscure. Although ELSs signify good prognosis in certain malignancies, we found that hepatic ELSs indicated poor prognosis for hepatocellular carcinoma (HCC). We studied an HCC mouse model that displayed abundant ELSs and found that they constituted immunopathological microniches wherein malignant hepatocyte progenitor cells appeared and thrived in a complex cellular and cytokine milieu until gaining self-sufficiency. The egress of progenitor cells and tumor formation were associated with the autocrine production of cytokines previously provided by the niche. ELSs developed via cooperation between the innate immune system and adaptive immune system, an event facilitated by activation of the transcription factor NF-κB and abolished by depletion of T cells. Such aberrant immunological foci might represent new targets for cancer therapy.

5 October 2022 in Nature
Verified
Journal Article
Closed access
PDF file
AFAveline Filliol
Aveline Filliol
YSYoshinobu Saito
Yoshinobu Saito
ANAjay Nair
Ajay Nair
DDDianne H. Dapito
Dianne H. Dapito
LYLe-Xing Yu
Le-Xing Yu
RSRobert F. Schwabe
Robert F. Schwabe

1 June 2015
Verified
Open access
PDF file
NGNicolas Goossens
Nicolas Goossens
SNShigeki Nakagawa
Shigeki Nakagawa
XSXiaochen Sun
Xiaochen Sun
YHYujin Hoshida
Yujin Hoshida
Cancer biomarker discovery and validation